Anti-Androgen
Showing 26 - 50 of >10,000
Breast Cancer, HER2-negative Breast Cancer, Metastatic Breast Cancer Trial in Madison (18F-DCFPyL)
Recruiting
- Breast Cancer
- +2 more
-
Madison, WisconsinUniversity of Wisconsin School of Medicine and Public Health
Oct 18, 2022
Neoadjuvant Therapy \ High Risk Prostate Cancer \ Docetaxel Trial in Nanjing (Docetaxel injection, Triptorelin Pamoate for
Active, not recruiting
- Neoadjuvant Therapy \ High Risk Prostate Cancer \ Docetaxel
- Docetaxel injection
- +2 more
-
Nanjing, Jiangsu, ChinaThe Affiliated Nanjing Drum Tower Hospital of Nanjing University
Dec 24, 2022
Polycystic Ovary Syndrome Trial in Shanghai (Dihydroartemisinin)
Active, not recruiting
- Polycystic Ovary Syndrome
-
Shanghai, ChinaZhongshan Hospital Fudan University
Jul 15, 2022
Castration-resistant Prostate Cancer, Homologous Recombination Deficiency Trial in Sydney (Testosterone Enanthate 100 MG/ML
Recruiting
- Castration-resistant Prostate Cancer
- Homologous Recombination Deficiency
- Testosterone Enanthate 100 MG/ML Injectable Solution
- Testosterone Enanthate 100 MG/ML Injectable Solution / Carboplatin AUC 5
-
Sydney, New South Wales, AustraliaKinghorn Cancer Centre, St. Vincent's Hospital
Dec 16, 2022
Hiv, Transgenderism Trial in Toronto (Biktarvy 50/200/25 Tab, Estradiol Tablets)
Recruiting
- Hiv
- Transgenderism
- Biktarvy 50/200/25 Tab
- Estradiol Tablets
-
Toronto, Ontario, CanadaMaple Leaf Research
Dec 15, 2022
Prostatic Tumors, Castration-Resistant Trial in Worldwide (Atezolizumab, Enzalutamide)
Active, not recruiting
- Prostatic Neoplasms, Castration-Resistant
-
Duarte, California
- +157 more
Oct 26, 2022
Recurrent Prostate Carcinoma, Stage IV Prostate Cancer AJCC v7 Trial in San Francisco (Ipilimumab, Laboratory Biomarker
Completed
- Recurrent Prostate Carcinoma
- Stage IV Prostate Cancer AJCC v7
- Ipilimumab
- +3 more
-
San Francisco, CaliforniaUCSF Medical Center-Mount Zion
Jul 29, 2020
Prostate Adenocarcinoma Trial run by the (bicalutamide, Stereotactic body radiation therapy)
Recruiting
- Prostate Adenocarcinoma
- bicalutamide
- Stereotactic body radiation therapy
-
Bethesda, MarylandNational Cancer Institute
Oct 1, 2021
In-vitro Diagnostic Test to Predict COVID-19 Mortality and
Recruiting
- SARS-CoV 2
- +5 more
- CAG length <22
- CAG length >=22
-
Madrid, SpainHospital Universitario Ramon y Cajal
Feb 17, 2022
Prostate Cancer Trial in Darlinghurst (SUBA-itraconazole, Hydroxychloroquine)
Recruiting
- Prostate Cancer
-
Darlinghurst, New South Wales, AustraliaSt Vincent's Hospital
May 3, 2022
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC) Trial in Nanjing (6-month course of antiandrogen drugs, Long-term course of
Recruiting
- Metastatic Hormone-Sensitive Prostate Cancer (mHSPC)
- 6-month course of antiandrogen drugs
- Long-term course of antiandrogen drugs
-
Nanjing, Jiangsu, ChinaUrology dpt, First Affiliated Hospital of Nanjing Medical Univer
Jul 13, 2023
Metastatic Castration-resistant Prostate Cancer Trial in New Haven (Testosterone Cypionate, Sipuleucel-T)
Not yet recruiting
- Metastatic Castration-resistant Prostate Cancer
- Testosterone Cypionate
- Sipuleucel-T
-
New Haven, ConnecticutYale Cancer Center
Oct 20, 2023
Treatment of Hypertrichosis With Intense Pulsed Light
Not yet recruiting
- Hypertrichosis
- Hirsutism - Hypertrichosis
- Intense pulsed light
-
Umeå, Västerbotten, SwedenNorrlands University Hospital
Mar 20, 2023
PCOS Trial in Guangzhou (DingKunDan(GuangYuYuan), Drospirenone and Ethinylestradiol Tablets (?))
Recruiting
- PCOS
- DingKunDan(GuangYuYuan)
- Drospirenone and Ethinylestradiol Tablets (Ⅱ)
-
Guangzhou, Guangdong, ChinaGuangdong Women and Children Health Hospital
May 21, 2023
Prostate Cancer, Prostate Disease Trial in Tampa (Nivolumab, Brachytherapy, External Beam Radiation Therapy)
Recruiting
- Prostate Cancer
- Prostate Disease
- Nivolumab
- +3 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center and Research Institute
Nov 11, 2022
Prostate Carcinoma Trial in Duarte (device, other, procedure)
Active, not recruiting
- Prostate Carcinoma
- Actigraph
- +2 more
-
Duarte, CaliforniaCity of Hope Medical Center
May 10, 2022
Advanced Prostate Cancer Trial in United Kingdom, United States (HPN424)
Active, not recruiting
- Advanced Prostate Cancer
- HPN424 In Part 1 (Dose Escalation)
- HPN424 In Part 2 (Dose Expansion)
-
Los Angeles, California
- +14 more
Jan 20, 2023
Prostatic Tumors Trial in New York (CC-90011, Abiraterone, Prednisone)
Recruiting
- Prostatic Neoplasms
- CC-90011
- +2 more
-
New York, New YorkMemorial Sloan-Kettering Cancer Center
Jul 21, 2022
Covid19, SARS-CoV Infection Trial in Brasilia (Proxalutamide, Standard of Care)
Withdrawn
- Covid19
- SARS-CoV Infection
- Proxalutamide
- Standard of Care
-
Brasilia, BrazilCorpometria Institute
Feb 17, 2022
Salivary Duct Carcinoma Trial in Nijmegen (Goserelin 10.8 mg, Bicalutamide 50 mg, Dutasteride 0.5 mg)
Not yet recruiting
- Salivary Duct Carcinoma
- Goserelin 10.8 mg
- +2 more
-
Nijmegen, Gelderland, NetherlandsRadboudumc
Aug 23, 2022
Prostate Cancer Trial in Canada, United States (Radiation Therapy, Enzalutamide, Bicalutamide)
Recruiting
- Prostate Cancer
- Radiation Therapy
- +3 more
-
Gilbert, Arizona
- +107 more
Mar 17, 2022
Protocol TRANS and QT Repolarization
Completed
- Transgender Persons
- QT Interval, Variation in
-
Pessac, FranceUniversity Hospital Bordeaux, France
May 9, 2023